Xencor Inc (NASDAQ:XNCR)
| 27.68 Delayed Data As of Jun 02 |  +0.54 / +1.99%Today’s Change | 19.36 Today|||52-Week Range 38.20 | +6.30% Year-to-Date |
Latest XNCR News | Press Releases
No recent news for Xencor Inc.
Today’s Trading
| Previous close | 27.14 |
| Today’s open | 27.30 |
| Day’s range | 26.97 - 27.68 |
| Volume | 5,517 |
| Average volume (3 months) | 339,506 |
| Market cap | $1.7B |
Data as of 3:59pm ET, 06/02/2023
Growth & Valuation
| Earnings growth (last year) | -165.35% |
| Earnings growth (this year) | -259.43% |
| Earnings growth (next 5 years) | +74.10% |
| Revenue growth (last year) | -40.18% |
| P/E ratio | NM |
| Price/Sales | 9.44 |
| Price/Book | 2.28 |
Competitors
| ---- | ||
| PTGXProtagonist Therapeu... | +0.72 | +2.62% |
| RCKTRocket Pharmaceutica... | +0.93 | +4.44% |
| BCRXBioCryst Pharmaceuti... | -0.05 | -0.60% |
Data as of 4:00pm ET, 06/02/2023
Financials
| Next reporting date | August 8, 2023 |
| EPS forecast (this quarter) | -$0.80 |
| Annual revenue (last year) | $164.6M |
| Annual profit (last year) | -$55.2M |
| Net profit margin | -33.53% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Monrovia, California |
Forecasts
